Lv4
530 积分 2022-08-15 加入
Broad Immunomodulatory Effects of the Dipeptidyl-peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Place-controlled WILLOW Trial
21小时前
已关闭
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
15天前
已完结
Broad Immunomodulatory Effects of the Dipeptidyl-peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Place-controlled WILLOW Trial
15天前
已完结
Rethinking bronchiectasis as an inflammatory disease
15天前
已完结
Psychometric Validation and Determination of the Minimal Clinically Important Difference for Bronchiectasis Health Questionnaire in Adults with Bronchiectasis
1个月前
已关闭
Psychometric Validation and Determination of the Minimal Clinically Important Difference for Bronchiectasis Health Questionnaire in Adults with Bronchiectasis
1个月前
已完结
Clinical Characteristics and Outcomes of the Phenotypes of COPD-Bronchiectasis Association
1个月前
已完结
Clinical Characteristics and Outcomes of the Phenotypes of COPD-Bronchiectasis Association
1个月前
已关闭
Clinical Characteristics and Outcomes of the Phenotypes of COPD-Bronchiectasis Association
1个月前
已完结
Increased TGFβ1, VEGF and IFN-γ in the Sputum of Severe Asthma Patients With Bronchiectasis
1个月前
已完结
皖公网安备34019202002308
